On July 19, 2018, the Department of Health and Human Services secretary Alex Azar and the Food and Drug Administration (FDA) commissioner Scott Gottlieb announced the formation of a new FDA working group to develop policy options for the importation of certain prescription drugs from outside the US.
Generic Drug Competition Through Importation
Comment
Show comments
Hide Comments
